32. Mestas J, Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172: 2731–2738. 33. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ (1999) Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll- like receptor 2. J Biol Chem 274: 17406–17409. 34. Treins C, Giorgetti-Peraldi S, Murdaca J, Monthouel-Kartmann MN, Van Obberghen E (2005) Regulation of hypoxia-inducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I. Mol Endocrinol 19: 1304–1317. 35. Wang GL, Jiang BH, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92: 5510–5514. 36. Pugh CW, O’Rourke JF, Nagao M, Gleadle JM, Ratcliffe PJ (1997) Activation of hypoxia-inducible factor-1; definition of regulatory domains within the alpha subunit. J Biol Chem 272: 11205–11214. 37. Semenza GL (2001) Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7: 345–350. 38. Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez, et al. (2000) Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem 275: 25130–25138. 39. Mansfield KD, Simon MC, Keith B (2004) Hypoxic reduction in cellular glutathione levels requires mitochondrial reactive oxygen species. J Appl Physiol 2004 97: 1358–1366. 40. Mancino A, Schioppa T, Larghi P, Pasqualini F, Nebuloni M, et al. Divergent effects of hypoxia on dendritic cell functions. Blood 112(9): 3723–3734. 41. Elia AR, Cappello P, Puppo M, Fraone T, Vanni C, et al. (2008) Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile. J Leukoc Biol 84: 1472–1482. TLR and HIF in Human DCs 42. Feliers D, Gorin Y, Ghosh-Choudhury G, Abboud HE, Kasinath BS (2006) Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species. Am J Physiol Renal Physiol 290: F927–936. 43. Chin K, Kurashima Y, Ogura T, Tajiri H, Yoshida S, et al. (1997) Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene 15: 437–442. 44. Slupski M, Szadujkis-Szadurski L, Grzesk G, Szadujkis-Szadurski R, Szadujkis- Szadurska K, et al. (2007) Guanylate cyclase activators influence reactivity of human mesenteric superior arteries retrieved and preserved in the same conditions as transplanted kidneys. Transplant Proc 39: 1350–1353. 45. Mentzer SJ, Guyre PM, Burakoff SJ, Faller DV (1986) Spontaneous aggregation as a mechanism for human monocyte purification. Cell Immunol 101: 312–319. 46. Obregon C, Rothen-Rutishauser B, Gitahi SK, Gehr P, Nicod LP (2006) Exovesicles from human activated dendritic cells fuse with resting dendritic cells, allowing them to present alloantigens. Am J Pathol 169: 2127–2136. 47. Spirig R, van Kooten C, Obregon C, Nicod L, Daha M, et al. (2008) The complement inhibitor low molecular weight dextran sulfate prevents TLR4- induced phenotypic and functional maturation of human dendritic cells. J Immunol 181: 878–890. 48. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179: 1109–1118. 49. Regamey N, Obregon C, Ferrari-Lacraz S, van Leer C, Chanson M, et al. (2007) Airway epithelial IL-15 transforms monocytes into dendritic cells. Am J Respir Cell Mol Biol 37: 75–84. PLoS ONE | www.plosone.org 12 June 2010 | Volume 5 | Issue 6 | e10983